Archive | October, 2009
Pfizer Wyeth acquisition could affect jobs (NYSE:PFE)
On a Thursday morning, Pfizer announced that they have successfully completed the acquisition of Wyeth following the receipt of regulatory approval from all the government authorities required by the merger agreement and approval by Wyeth shareholders.
Continue reading...Protalix Top Line Results (AMEX:PLX)
16 October 2009 – 11:00 am PST
Comments Off
On Thursday, shares of Protalix BioTherapeutics moved upwards after they announced the positive results from their Phase 3 clinical trial of UPLYSO drug for the treatment of Gaucher disease.
Continue reading...Amgen Facing Delays (NASDAQ:AMGN)
16 October 2009 – 10:45 am PST
Comments Off
Amgen Inc is not really sure if they will have to wait or not but many of the biotech investors have speculated that Amgen’s Bone drug may have to face significant delays in the final decision by the Food and Drug Administration.
Continue reading...OxiGENE’s New Merger (NASDAQ:OXGN)
16 October 2009 – 10:25 am PST
Comments Off
OxiGENE and VaxGen on Thursday morning announced that they have entered into a definitive merger agreement where OxiGENE will acquire VaxGen in exchange for common stock of OxiGENE Inc.
Continue reading...Acorda Gains Momentum (NASDAQ:ACOR)
16 October 2009 – 10:09 am PST
Comments Off
Acorda Therapeutics had a not so very good Wednesday morning with NASDAQ halting their trading on the stock market as the review by the Food and Drug Administration panel was due.
Continue reading...Ziopharm Oncology Soars High (NASDAQ:ZIOP)
16 October 2009 – 6:30 am PST
Comments Off
On early Wednesday morning shares of Ziopharm Oncology moved up a whopping 37 percent after they announced the release of the promising data of their cancer drug Zymafos.
Continue reading...Acorda Trading Halted (NASDAQ:ACOR)
16 October 2009 – 6:00 am PST
Comments Off
It was not a good start for Acorda Therapeutics on Wednesday morning when NASDAQ decided to halt the trading of Acorda Therapeutics shares until the experts have voted on Acorda’s new MS drug.
Continue reading...FDA approves Acorda’s MS drug (NASDAQ:ACOR)
16 October 2009 – 5:30 am PST
Comments Off
It was a bad news for Acorda Therapeutics when they heard the news that NASDAQ has halted their trading and shares of Acorda Therapeutics were 18 percent down on the stock market.
Continue reading...Progenics-Wyeth Agreement (NASDAQ:PGNX)
16 October 2009 – 5:00 am PST
Comments Off
Progenics Pharmaceuticals have announced that they have entered an agreement with Wyeth Pharmaceuticals under which they will be regaining all the worldwide rights to the Relistor franchise from Wyeth Pharmaceuticals.
Continue reading...Merck Galapagos Deal (NYSE:MRK)
16 October 2009 – 4:30 am PST
Comments Off
Early Wednesday afternoon, Merck announced that they have made a decision of research collaboration with Galapagos NV.
Continue reading...
16 October 2009 – 11:15 am PST
Comments Off